Literature DB >> 24330011

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).

Ian Williams, Duncan Churchill, Jane Anderson, Marta Boffito, Mark Bower, Gus Cairns, Kate Cwynarski, Simon Edwards, Sarah Fidler, Martin Fisher, Andrew Freedman, Anna Maria Geretti, Yvonne Gilleece, Rob Horne, Margaret Johnson, Saye Khoo, Clifford Leen, Neal Marshall, Mark Nelson, Chloe Orkin, Nicholas Paton, Andrew Phillips, Frank Post, Anton Pozniak, Caroline Sabin, Roy Trevelion, Andrew Ustianowski, John Walsh, Laura Waters, Edmund Wilkins, Alan Winston, Mike Youle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24330011     DOI： 10.1111/hiv.12119

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  68 in total

1.  HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

Authors:  Borja Mora-Peris; Alan Winston; Lucy Garvey; Laura J Else; Robin J Shattock; Carolina Herrera
Journal:  J Antimicrob Chemother       Date:  2015-10-15       Impact factor: 5.790

Review 2.  HIV treatment as prevention in men who have sex with men: examining the evidence.

Authors:  Patrick O'Byrne; Paul MacPherson
Journal:  CMAJ       Date:  2015-12-22       Impact factor: 8.262

3.  Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.

Authors:  A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch
Journal:  HIV Med       Date:  2015-02-03       Impact factor: 3.180

Review 4.  Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.

Authors:  Victoria Tittle; Lauren Bull; Marta Boffito; Nneka Nwokolo
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

5.  2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

Authors:  Andrew D Revell; Dechao Wang; Maria-Jesus Perez-Elias; Robin Wood; Dolphina Cogill; Hugo Tempelman; Raph L Hamers; Peter Reiss; Ard I van Sighem; Catherine A Rehm; Anton Pozniak; Julio S G Montaner; H Clifford Lane; Brendan A Larder
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

6.  An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.

Authors:  Andrew D Revell; Dechao Wang; Robin Wood; Carl Morrow; Hugo Tempelman; Raph L Hamers; Peter Reiss; Ard I van Sighem; Mark Nelson; Julio S G Montaner; H Clifford Lane; Brendan A Larder
Journal:  J Antimicrob Chemother       Date:  2016-06-20       Impact factor: 5.790

7.  In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.

Authors:  Christian Callebaut; George Stepan; Yang Tian; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

8.  Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.

Authors:  Alessandra Amendola; Patrizia Marsella; Maria Bloisi; Federica Forbici; Claudio Angeletti; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

Review 9.  Elvitegravir: a review of its use in adults with HIV-1 infection.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

10.  Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.

Authors:  Damalie Nakanjako; Agnes N Kiragga; Beverly S Musick; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Lameck Diero; Patrick Oyaro; Emanuel Lugina; John C Ssali; Andrew Kambugu; Philippa Easterbrook
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.